Thesis

A conjunction of spheres : colloidal quantum dot microlasers towards chipscale biosensors

Creator
Rights statement
Awarding institution
  • University of Strathclyde
Date of award
  • 2026
Thesis identifier
  • T17678
Person Identifier (Local)
  • 202084509
Qualification Level
Qualification Name
Department, School or Faculty
Abstract
  • Biosensing is one of the most important current areas of research with the COVID19 pandemic highlighting the need for easy to use, reliable, and portable biosensors.Whispering Gallery Mode (WGM) lasers have been a popular choice for biosensingresearch due to their capability for label-free sensing, rapid detection response, highsensitivity, and high signal to noise ratio when operating above the lasing threshold.Colloidal Quantum Dots (CQDs) are an important class of new material and are attractive for use in lasers due to their high density of states, high photostability, and highquantum yield. In 2018, the fabrication of microspheres consisting entirely of CQDs,called supraparticles (SPs), which could demonstrate WGM lasing was first publishedand inspired a new area of research due to their promising use as tiny lasers. In thiswork, the focus was on the use of these CQD supraparticles (SPs) as laser biosensorsbecause the microscale size of these SP lasers would enable their integration into a microfluidic chip to create easy to use and portable devices. First, the fabrication of theseSPs was achieved using an emulsion templated fabrication, along with two additionalvariants, yielding SPs with laser thresholds as low as 4.1 ± 0.4 mJ/cm2 under freespace excitation. To be able to use these SPs as laser biosensors, SPs were modifiedwith the protein Neutravidin and a DNA aptamer with 15 bases called the ThrombinBinding Aptamer (TBA-15). Both Neutravidin-coated SPs and TBA-15 coated SPs(TBA-SPs) retained lasing functionality post- functionalisation with thresholds of 25.1± 3.5 mJ/cm2 and 19.8 ± 2.7 mJ/cm2, respectively. Finally, a crude study to demonstrate biosensing capabilities of TBA-SPs for the protein thrombin in solution, with apossible detection limit around 1.5 mg/mL. This is an exciting new development whichcan act as a platform for further study and to create a lab on a chip sensing device.
Advisor / supervisor
  • Laurand, Nicolas
Resource Type
DOI

Relations

Items